Antiphospholipid Antibodies and the Risk of Stroke in Urban and Rural Tanzania | Zendy

Quirijn de Mast | Zendy; Jessica E. Molhoek | Zendy; André van der Ven | Zendy; William K. Gray | Zendy; Philip G. de Groot | Zendy; Ahmed Jusabani | Zendy; Ferdinand Mugusi | Zendy; Rolf T. Urbanus | Zendy; Richard Walker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antiphospholipid Antibodies and the Risk of Stroke in Urban and Rural Tanzania

Author(s) -

Quirijn de Mast,

Jessica E. Molhoek,

André van der Ven,

William K. Gray,

Philip G. de Groot,

Ahmed Jusabani,

Ferdinand Mugusi,

Rolf T. Urbanus,

Richard Walker

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.013760

Subject(s) - medicine , odds ratio , lupus anticoagulant , stroke (engine) , confidence interval , immunology , tanzania , population , risk factor , hazard ratio , antibody , environmental health , mechanical engineering , environmental science , environmental planning , engineering

The burden of stroke is high in sub-Saharan Africa, and improved knowledge of risk factors is needed. Antiphospholipid antibodies are a common acquired stroke risk factor in young individuals. Antiphospholipid antibodies may be induced by infectious diseases. Sub-Saharan Africa has a high infectious burden, and we analyzed the contribution of antiphospholipid antibodies to the risk of stroke in an incident population from rural and urban Tanzania.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research